PLD Pharma Services

Covering a 135,000ft² area, our Miami facility is registered with the FDA and complies fully with current good manufacturing practice (cGMP) guidelines. It has the capacity for R&D, process development and small-scale launches, including pilot-scale cGMP manufacturing and packaging to support pilot pha...

PLD has a library of more than 800 formulations and more than 40 years of Rx formulation development experience. 

PLD Pharma Services has responded to the increasing demand for gummies by adding gummy manufacturing capabilities, including a small line for R&D and scale up, as well as four additional commercial lines with an anticipated capacity of 1.2bn gummies annually. We are currently working with customers to ...

At PLD Pharma Services our analytical testing lab is also a development lab where we develop and optimize analytical methods that are robust and QC-friendly. We ensure that methods are efficient, reproducible, and aligned with both regulatory expectations and commercial manufacturing needs. 
q...

To ensure the seamless transition from pilot manufacturing, PLD starts with small-scale production equipment in the development process that has identical operational attributes to what will be used in full-scale commercial manufacturing all under the supervision of a single project manager to ensure that ...

Lessons Learned: Choosing & Managing a CDMOAvéma Pharma Solutions, a division of PL Developments (PLD), is in the unique position being both a consumer and supplier of global CDMO services for both OTC and rX products. In this presentation, we’ll explore the lessons we have learned from managing our own CMOs that have allowed us to build a better CDMO model for our Avéma customers. We’ll address the areas that can help speed up your time-to-market, keep development costs under control, and smooth the FDA approval and commercial launch process. Watch our webinar at https://app.webinar.net/K2OlZE6JLx9?mcc=WebsitePost